![deepak Kulkarni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deepak Kulkarni is currently working as a Director at Corium LLC.
Prior to this, he worked as a Managing Director at Webster Equity Partners, LLC from 2022 to 2023.
| Companies | Position | Start |
|---|---|---|
Corium LLC
 Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Webster Equity Partners, LLC
 Webster Equity Partners, LLC Investment ManagersFinance Webster Equity Partners invests in middle market companies located in the United States with revenues of USD 20 - 200 million and EBITDA of USD 5 - 20 million. The firm focuses on a broad range of sectors. It participates in MBOs and growth capital transactions. The firm also acquires controlling interest. | Private Equity Analyst | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Webster Equity Partners, LLC
Webster Equity Partners, LLC Investment ManagersFinance Webster Equity Partners invests in middle market companies located in the United States with revenues of USD 20 - 200 million and EBITDA of USD 5 - 20 million. The firm focuses on a broad range of sectors. It participates in MBOs and growth capital transactions. The firm also acquires controlling interest. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
